Gasgon fundraises €2.25m to launch AirVault device
Gasgon Medical has raised €2.25 million to ramp up development of its AirVault technology, intended to make IV infusion safer and more accurate. This funding enables the company to grow the team rapidly and deploy resources in manufacturing and commercialisation of its patent-pending technology.
Gasgon crowned overall Seedcorn 2021 Winners
We are so proud to have been awarded the top prize as overall winners of the prestigious InterTradeIreland 2021 Seedcorn competition for the island of Ireland!!
This competition has taken a long but rewarding deep dive into our business plan and investment strategy over the past several months. The prize is a huge €100,000, which will help us to achieve our goals, grow the team and launch products.
Swirl SAFE-infusion project awarded €3m in EU funding
Gasgon Medical is proud to work alongside a consortium of great partners, including Tada Medical and Remote Signals, to determine if our technology can be used to improve infusion of IV drugs. The two-year study will include manufacturing, validation and a multi-centre clinical trial in hospitals CHUC (Portugal) and PSSJD (Spain) ahead of regulatory approval and market launch by 2023.
Collaborating to improve patient outcomes
Gasgon Medical is honoured to be working with the clinical team at Centro Hospitalar e Universitário de Coimbra (CHUC), a leading institute for healthcare in Portugal. Our project, SAFE-Infusion, has been selected by CHUC to further their commitment to improving patient safety and healthcare performance. We will work closely together to identify opportunities to deliver better outcomes and ensure patients across Portugal continue to be offered the best healthcare treatments, with safety and quality at the core.
Ready for ACTION in Boston
Gasgon Medical was recently selected for the InterACTION program, one of just 5 companies from an international cohort (Israel, Spain, India, US, Ireland). With a particular focus on Boston and the surrounding New England region as a market entry location, this program delivered mentoring and focused insights from leading domain experts including; FDA regulatory pathway, legal frameworks, investment and sales strategy. Gasgon was selected alongside other leading medical product companies looking to expand our international network and fast track entry to the US market.
InterACTION Healthcare 2020 program is an initiative by ACTION Innovation Network. ACTION Innovation Network (“ACTION”) is an association of technology innovation centers that represent an established community of committed partners from industry, academics, private sector, and government in the Boston/greater Boston area.
Gasgon selected for funding under EIC SME Instrument Phase 1
Gasgon Medical has been selected by European Commission for funding and acceleration as part of the final SME Instrument Phase 1. Out of 3,299 entries, just 283 projects across 31 European countries have been selected for funding in this final round. A great boost for Gasgon Medical as we launch our medical products to improve IV fluid therapy for patients worldwide.
EIT Health European Health Catapult semi-finals
Gasgon Medical is excited to be selected in the top 14 European MedTech companies to compete at the prestigious EIT Health European Health Catapult semifinals, taking place in San Sebastian, Spain. The European Health Catapult, which has been called one of the top competitions for biotech start-ups in Europe, is designed to identify and accelerate promising European start-ups in the categories of biotech, medtech and digital health.
EIT Health Headstart Competition 2018
Gasgon Medical is honoured to be recognised as one of the top 10 Medtech startups in UK & Ireland, winning €50,000 funding and supports from EIT Health Headstart Funding Programme 2018. The finals took place in Liverpool, with 20 teams from all over the UK and Ireland completing a 2 day bootcamp before competing for prizes. The funding enables further development of our devices, with supports including mentoring and Living Labs from across Europe provided by EIT Health.
Gasgon Medical wins at Ireland's Best Young Entrepreneur
Gasgon won IBYE’s Best New Idea category from LEO South Cork and the title of ‘Best Young Entrepreneur’ for the South Cork region. The business also received €7,000 investment, supported by the Local Enterprise Office in South Cork.
National College Entrepreneur of the Year
Vincent Forde, a student from Cork Institute of Technology, has won the Enterprise Ireland Student Entrepreneur of the Year Award and been named ‘College Entrepreneur of the Year 2016’ for the whole island of Ireland. Selected by an expert panel, the project was highlighted for its novel solution to IV bubbles.
Gasgon meets project partners
Gasgon Medical showcased updates to its product and outlined various development achievements that underpin technical and regulatory work to SWIRL partners in Sweden. Our hospital partners engaged in open discussion on ethical and regulatory submission requirements for each country represented, Spain and Portugal.
Finalist in Future Health Summit Awards
Gasgon Medical was shortlisted as a finalist for the Future Health Summit 2021 Innovation award. We are proud to be selected as one of 8 international companies to pitch live on stage at the Summit in Dublin. While not an overall winner on the day we enjoyed attending two days of discussions on the future of our health, with leadership insights on innovation, entrepreneurship and disruption in healthcare.
Neighborhood welcomes Gasgon
To support our regulatory journey ahead of planned EU launch, Gasgon is delighted to join the prestigious Paris-based Neighborhood program, delivered by Voisin Consulting.
Collaborating to deliver better patient outcomes
We are very proud to be working with the great team at Fundació Sant Joan de Déu (FSJD), a leading Barcelona research foundation, to prepare our IV infusion devices for launch. The clinical team at Parc Sanitari Sant Joan de Déu (PSSJD), the healthcare campus linked to FSJD, is committed to improving safety and clinical outcomes for their patients, and have identified strong potential in Gasgon's technology. We will continue to investigate opportunities to develop devices that improve IV fluid management together as part of our commitment to improving patient care and clinical safety.
to increase occupational safety
Gasgon is excited to announce a joint collaboration project with Tada Medical, a Sweden-based developer of novel IV components, to improve safety of IV infusions for patients and care providers. Recently a joint poster was accepted for display at the European Oncology Nurses Society (EONS) annual congress, in conjunction with European Society for Medical Oncology (ESMO). This project examines how the shifting of IV therapy from the hospital to the home will pose a challenge with regards to risk management. Two of the most important safety issues are identified to be the risk of vascular air embolism and IV line dislodgement. Exposure to hazardous drugs is a leading cause of harm for nurses, a problem which will continue into the home. Through our collaboration, both Gasgon and Tada will continue working to improve safety of hazardous drug infusions for patients, nurses and care providers across all settings.
Gasgon awarded 2nd place overall at European Health Catapult Finals
Proud to report that Gasgon Medical has been awarded 2nd place overall in MedTech category of the prestigious EIT Health European Health Catapult in Paris, the biggest competition for Medtech, Biotech and Digitalhealth start-ups in Europe. With over 200 incredible start-ups from all over the continent competing, validation at this level from leading healthcare investors and stakeholders highlights the exciting future ahead for Gasgon Medical as we launch new technologies to improve the way IV fluid medicine is administered for patients globally.
5 innovative European sci-tech startups you should know about in 2019
Gasgon Medical is featured among Silicon Canal's article, entitled " 5 innovative European sci-tech startups you should know about in 2019 "
CEO presents at European Life Sciences CEO Forum in Zurich
On February 25-26th, Gasgon Medical attended the Sachs 12th Annual European Life Sciences CEO Forum (ELSCEO), in Zurich, Switzerland, presenting on-stage during the Rising Stars: Start-up Show Case Session.
EIT Health selected Gasgon Medical as one of only five startup companies from across Europe to showcase its innovative business, providing full support for the two-day event which included seminar panels, one-to-one meetings and networking activities.
The event was attended by investors and corporate leaders from powerhouse companies in the LifeScience sector, with a focus on scaling opportunities in biotech, therapeutics, medtech, and digital health. CEO of Gasgon Medical, Vincent Forde, presented our exciting technology that is overcoming the challenge of managing gas bubbles that cause harm, including stroke and heart attack, during common IV infusions.
Gasgon Medical recognised at the Early Career Awards
Gasgon Medical was awarded the top award in the 'Special Recognition' category at the glittering black tie event in Dublin's Mansion House...
Gasgon Medical success at CIT Prize for Innovation
Innovative CIT student Vincent Forde has won CIT Entrepreneur of the Year 2016, the top honour in the Cork Institute of Technology annual awards.
Gasgon Medical listed as 'One to Watch' in 2022
In early March, Taoiseach Micheál Martin, TD, launched a list compiled by Health Innovation Hub Ireland (HIHI) of 20 Irish companies that are disrupting the health-tech sector with new innovations, including Gasgon Medical. Our CTO, Dan Stapleton, was interviewed as part of the promotion for the HIHI Open Call - read more in the Innovation Brochure here.
Gasgon Medical meets with Irish healthcare workers
Health Innovation Hub Ireland has selected Gasgon Medical for acceleration within the Irish healthcare system. Recently we took part in a focus group with leadership of South Infirmary Victoria University Hospital and Bantry General Hospital in Cork, with attending staff giving deep and insightful feedback on our product design for AirVault. Through direct engagement Gasgon Medical is determined to deliver the most effective solutions for real healthcare challenges.
Results of H2020 funding published by EU Commission
Medicine’s bubble trouble popped by innovative valve; An article has been published on the 'Results in Brief' section of the European Commission's CORDIS website, detailing our use of grant support from the EC Horizon 2020 Phase 1 to discover exciting new areas of impact for our technology. It can be read here...
Gasgon: Supporting nurses in Europe and beyond
Gasgon Medical was delighted to meet with Paul De Raeve, Secretary General of the European Federation of Nurses in Brussels, to discuss the important role EFN carries out advocating strongly for its 3 million nurse members across the EU, as well as the wider role MedTech innovation can play to reduce the burden of care at the bedside. We look forward to continuing to work closely with EFN to support our amazing nurses.
Gasgon; Accelerated by
EIC Phase 1
As part of the EIC SME Instrument Phase 1 Feasibility Grant (No. 887764) Gasgon Medical has undertaken commercial and technical feasibility activities to determine the practical applications for its novel technology in the healthcare marketplace. Through collaboration with clinicians and hospitals across Europe, Gasgon has identified a broad range of areas that would benefit from its proprietary technology, including Paediatrics, Cardiology, Intensive and Oncology. As a result of this support from EIC, Gasgon Medical has developed key clinical and technical partnerships to rapidly pursue the commercial potential. On the level of H2020 priorities, this project and its outcomes will address “Health, demographic change and wellbeing” by improving IV therapy safety in-hospital and at home, benefiting EU taxpayers and patients.
Gasgon Medical awarded Seal of Excellence by European Commission
Gasgon Medical is proud to be recognised by a panel of independent international experts in the highly competitive SME Instrument evaluation process. This award supports our ambitions to bring important new medical devices to market and further validates our business plans, particularly in the areas of excellence, impact, quality and efficiency of implementation. Holders of the Seal of Excellence are invited as members to the Access4SMEs community, which aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
Gasgon Medical wins in Boston
At the finals, taking place in Boston, Gasgon Medical was chosen as one of two top Irish startups to be fast-tracked into MassChallenge's global accelerator, to take place later this year. From a competitive group of MedTech and LifeScience startups chosen from across Ireland, Gasgon Medical and Cortechs Connect were selected as leading projects and offered the chance to return to Boston for final pitching, with an opportunity to participate in the highly prestigious MassChallenge cohort of 2018.
On the road to MassChallenge Boston
Gasgon Medical was recently selected to travel to Boston as one of the twelve Irish MedTech and LifeScience startups, chosen from a national campaign run by Cork County Council...
Gasgon Medical competes at the University Startup World Cup
Gasgon Medical was in Copenhagen recently, selected to represent Ireland at the Venture Cup University Startup World Cup, supported by Cork Institute of Technology. Vincent and Conor spent one week in bootcamp before the final pitching took place in Copenhagen's Institute of Technology. Gasgon was competing with winning entries from 55 countries and arrived home with the 'HealthTech Leadership Award'.